Coral Laboratories Ltd.
BSE: 524506
₹643.15
₹4.90
(0.77%)
As on 28-Aug-2026IST
Market cap
₹230 Cr
Revenue (TTM)
₹97 Cr
P/E Ratio
12
P/B Ratio
1.1
Div. Yield
0.3 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹19 Cr
-
ROE
12.8 %
-
ROCE
17 %
-
Industry P/E
33.99
-
EV/EBITDA
5.7
-
Debt to Equity
0
-
Book Value
₹600.4
-
EPS
₹53.1
-
Face value
10
-
Shares outstanding
3,572,600
10 Years Aggregate
CFO
₹37.54 Cr
EBITDA
₹143.30 Cr
Net Profit
₹127.48 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Coral Laboratories
| 46.7 | 15.6 | 35.5 | 39.9 | 34.1 | 9.3 | 3.2 |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Coral Laboratories
| -46.2 | 81.9 | 35.0 | 3.6 | -0.1 | 116.0 | -62.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Coral Laboratories
|
643.2 | 229.8 | 96.7 | 19.2 | 16.7 | 9 | 12 | 1.1 |
| 7,106.5 | 17,765.6 | 2,432.1 | 169.6 | 8.7 | 20.8 | 104.7 | 19.6 | |
| 2,517.2 | 19,125.3 | 2,287.3 | 678.1 | 31.4 | 19.7 | 28.7 | 5.1 | |
| 2,079.5 | 12,740.0 | 1,479.1 | 198.6 | 18.6 | 30.3 | 64 | 15.8 | |
| 1,314.8 | 18,252.8 | 3,229.7 | 666.9 | 26.6 | 18.8 | 28.3 | 4.5 | |
| 4,703.8 | 21,500.8 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.2 | 4.9 | |
| 5,670.5 | 9,412.3 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.4 | 15.3 | |
| 3,181.6 | 7,325.6 | 1,805.2 | 323.8 | 24.7 | 43.7 | 22.6 | 8.9 | |
| 903.8 | 17,685.5 | 1,682.5 | 273.5 | 21.0 | 11.1 | 59.5 | 6.6 | |
| 1,019.9 | 9,406.7 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.3 | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Coral Laboratories
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory,... antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India. Read more
-
Incorporated
1997
-
Chairman
Sushma Kadkade
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Coral Laboratories
What is the current share price of Coral Laboratories Ltd Today?
The share price of Coral Laboratories Ltd is ₹643.15 (BSE) as of 28-Aug-2026 IST. Coral Laboratories Ltd has given a return of 34.05% in the last 3 years.
What is the current PB & PE ratio of Coral Laboratories Ltd?
The P/E ratio of Coral Laboratories Ltd is 11.96 times as on 28-Aug-2026, a 65 discount to its peers’ median range of 33.99 times.
The P/B ratio of Coral Laboratories Ltd is 1.07 times as on 28-Aug-2026, a 79 discount to its peers’ median range of 5.06 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
10.37 |
1.25 |
2024 |
8.40 |
0.75 |
2023 |
12.69 |
0.53 |
2022 |
10.08 |
0.58 |
2021 |
8.49 |
0.84 |
What is the 52 Week High and Low of Coral Laboratories Ltd?
The 52-week high and low of Coral Laboratories Ltd are Rs 679.00 and Rs 360.00 as of 30-Aug-2026.
What is the market cap of Coral Laboratories Ltd?
Coral Laboratories Ltd has a market capitalisation of ₹ 230 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Coral Laboratories Ltd?
Before investing in Coral Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.